Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.
Identifieur interne : 000226 ( Main/Exploration ); précédent : 000225; suivant : 000227Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.
Auteurs : Dinah Kanate ; David Folk ; Sharon Cirone ; Janet Gordon ; Mike Kirlew ; Terri Veale ; Natalie Bocking ; Sara Rea ; Len KellySource :
- Canadian family physician Medecin de famille canadien [ 1715-5258 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Buprénorphine (administration et posologie), Buprénorphine (usage thérapeutique), Femelle, Humains, Jeune adulte, Mâle, Naloxone (administration et posologie), Naloxone (usage thérapeutique), Ontario, Patients en consultation externe (psychologie), Services de santé communautaires (), Traitement de substitution aux opiacés (), Troubles liés aux opiacés (psychologie), Troubles liés aux opiacés (rééducation et réadaptation), Troubles liés aux opiacés (traitement médicamenteux).
- MESH :
- administration et posologie : Buprénorphine, Naloxone.
- psychologie : Patients en consultation externe, Troubles liés aux opiacés.
- rééducation et réadaptation : Troubles liés aux opiacés.
- traitement médicamenteux : Troubles liés aux opiacés.
- usage thérapeutique : Buprénorphine, Naloxone.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Jeune adulte, Mâle, Ontario, Services de santé communautaires, Traitement de substitution aux opiacés.
English descriptors
- KwdEn :
- Adult, Buprenorphine (administration & dosage), Buprenorphine (therapeutic use), Community Health Services (methods), Female, Humans, Male, Middle Aged, Naloxone (administration & dosage), Naloxone (therapeutic use), Ontario, Opiate Substitution Treatment (methods), Opioid-Related Disorders (drug therapy), Opioid-Related Disorders (psychology), Opioid-Related Disorders (rehabilitation), Outpatients (psychology), Young Adult.
- MESH :
- chemical , administration & dosage : Buprenorphine, Naloxone.
- chemical , therapeutic use : Buprenorphine, Naloxone.
- geographic : Ontario.
- drug therapy : Opioid-Related Disorders.
- methods : Community Health Services, Opiate Substitution Treatment.
- psychology : Opioid-Related Disorders, Outpatients.
- rehabilitation : Opioid-Related Disorders.
- Adult, Female, Humans, Male, Middle Aged, Young Adult.
Abstract
OBJECTIVE
To document the development of unique opioid-dependence treatment in remote communities that combines First Nations healing strategies and substitution therapy with buprenorphine-naloxone.
DESIGN
Quantitative measurements of community wellness and response to community-based opioid-dependence treatment.
SETTING
Remote First Nations community in northwestern Ontario.
PARTICIPANTS
A total of 140 self-referred opioid-dependent community members.
INTERVENTION
Community-developed program of First Nations healing, addiction treatment, and substitution therapy.
MAIN OUTCOME MEASURES
Community-wide measures of wellness: number of criminal charges, addiction-related medical evacuations, child protection agency cases, school attendance, and attendance at community events.
RESULTS
The age-adjusted adult rate of opioid-dependence treatment was 41%. One year after the development of the in-community healing and substitution therapy program for opioid dependence, police criminal charges had fallen by 61.1%, child protection cases had fallen by 58.3%, school attendance had increased by 33.3%, and seasonal influenza immunizations had dramatically gone up by 350.0%. Attendance at community events is now robust, and sales at the local general store have gone up almost 20%.
CONCLUSION
Community-wide wellness measures have undergone dramatic public health changes since the development of a First Nations healing program involving opioid substitution therapy with buprenorphine-naloxone. Funding for such programs is ad hoc and temporary, and this threatens the survival of the described program and other such programs developing in this region, which has been strongly affected by an opioid-dependence epidemic.
PubMed: 25821874
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.</title><author><name sortKey="Kanate, Dinah" sort="Kanate, Dinah" uniqKey="Kanate D" first="Dinah" last="Kanate">Dinah Kanate</name></author><author><name sortKey="Folk, David" sort="Folk, David" uniqKey="Folk D" first="David" last="Folk">David Folk</name></author><author><name sortKey="Cirone, Sharon" sort="Cirone, Sharon" uniqKey="Cirone S" first="Sharon" last="Cirone">Sharon Cirone</name></author><author><name sortKey="Gordon, Janet" sort="Gordon, Janet" uniqKey="Gordon J" first="Janet" last="Gordon">Janet Gordon</name></author><author><name sortKey="Kirlew, Mike" sort="Kirlew, Mike" uniqKey="Kirlew M" first="Mike" last="Kirlew">Mike Kirlew</name></author><author><name sortKey="Veale, Terri" sort="Veale, Terri" uniqKey="Veale T" first="Terri" last="Veale">Terri Veale</name></author><author><name sortKey="Bocking, Natalie" sort="Bocking, Natalie" uniqKey="Bocking N" first="Natalie" last="Bocking">Natalie Bocking</name></author><author><name sortKey="Rea, Sara" sort="Rea, Sara" uniqKey="Rea S" first="Sara" last="Rea">Sara Rea</name></author><author><name sortKey="Kelly, Len" sort="Kelly, Len" uniqKey="Kelly L" first="Len" last="Kelly">Len Kelly</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25821874</idno><idno type="pmid">25821874</idno><idno type="wicri:Area/Main/Corpus">000216</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000216</idno><idno type="wicri:Area/Main/Curation">000216</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000216</idno><idno type="wicri:Area/Main/Exploration">000216</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.</title><author><name sortKey="Kanate, Dinah" sort="Kanate, Dinah" uniqKey="Kanate D" first="Dinah" last="Kanate">Dinah Kanate</name></author><author><name sortKey="Folk, David" sort="Folk, David" uniqKey="Folk D" first="David" last="Folk">David Folk</name></author><author><name sortKey="Cirone, Sharon" sort="Cirone, Sharon" uniqKey="Cirone S" first="Sharon" last="Cirone">Sharon Cirone</name></author><author><name sortKey="Gordon, Janet" sort="Gordon, Janet" uniqKey="Gordon J" first="Janet" last="Gordon">Janet Gordon</name></author><author><name sortKey="Kirlew, Mike" sort="Kirlew, Mike" uniqKey="Kirlew M" first="Mike" last="Kirlew">Mike Kirlew</name></author><author><name sortKey="Veale, Terri" sort="Veale, Terri" uniqKey="Veale T" first="Terri" last="Veale">Terri Veale</name></author><author><name sortKey="Bocking, Natalie" sort="Bocking, Natalie" uniqKey="Bocking N" first="Natalie" last="Bocking">Natalie Bocking</name></author><author><name sortKey="Rea, Sara" sort="Rea, Sara" uniqKey="Rea S" first="Sara" last="Rea">Sara Rea</name></author><author><name sortKey="Kelly, Len" sort="Kelly, Len" uniqKey="Kelly L" first="Len" last="Kelly">Len Kelly</name></author></analytic><series><title level="j">Canadian family physician Medecin de famille canadien</title><idno type="eISSN">1715-5258</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Buprenorphine (administration & dosage)</term><term>Buprenorphine (therapeutic use)</term><term>Community Health Services (methods)</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Naloxone (administration & dosage)</term><term>Naloxone (therapeutic use)</term><term>Ontario</term><term>Opiate Substitution Treatment (methods)</term><term>Opioid-Related Disorders (drug therapy)</term><term>Opioid-Related Disorders (psychology)</term><term>Opioid-Related Disorders (rehabilitation)</term><term>Outpatients (psychology)</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Buprénorphine (administration et posologie)</term><term>Buprénorphine (usage thérapeutique)</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Naloxone (administration et posologie)</term><term>Naloxone (usage thérapeutique)</term><term>Ontario</term><term>Patients en consultation externe (psychologie)</term><term>Services de santé communautaires ()</term><term>Traitement de substitution aux opiacés ()</term><term>Troubles liés aux opiacés (psychologie)</term><term>Troubles liés aux opiacés (rééducation et réadaptation)</term><term>Troubles liés aux opiacés (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Buprenorphine</term><term>Naloxone</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Buprenorphine</term><term>Naloxone</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Ontario</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Buprénorphine</term><term>Naloxone</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Opioid-Related Disorders</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Community Health Services</term><term>Opiate Substitution Treatment</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Patients en consultation externe</term><term>Troubles liés aux opiacés</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Opioid-Related Disorders</term><term>Outpatients</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Opioid-Related Disorders</term></keywords><keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Troubles liés aux opiacés</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Troubles liés aux opiacés</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Buprénorphine</term><term>Naloxone</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Ontario</term><term>Services de santé communautaires</term><term>Traitement de substitution aux opiacés</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>To document the development of unique opioid-dependence treatment in remote communities that combines First Nations healing strategies and substitution therapy with buprenorphine-naloxone.</p></div><div type="abstract" xml:lang="en"><p><b>DESIGN</b></p><p>Quantitative measurements of community wellness and response to community-based opioid-dependence treatment.</p></div><div type="abstract" xml:lang="en"><p><b>SETTING</b></p><p>Remote First Nations community in northwestern Ontario.</p></div><div type="abstract" xml:lang="en"><p><b>PARTICIPANTS</b></p><p>A total of 140 self-referred opioid-dependent community members.</p></div><div type="abstract" xml:lang="en"><p><b>INTERVENTION</b></p><p>Community-developed program of First Nations healing, addiction treatment, and substitution therapy.</p></div><div type="abstract" xml:lang="en"><p><b>MAIN OUTCOME MEASURES</b></p><p>Community-wide measures of wellness: number of criminal charges, addiction-related medical evacuations, child protection agency cases, school attendance, and attendance at community events.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>The age-adjusted adult rate of opioid-dependence treatment was 41%. One year after the development of the in-community healing and substitution therapy program for opioid dependence, police criminal charges had fallen by 61.1%, child protection cases had fallen by 58.3%, school attendance had increased by 33.3%, and seasonal influenza immunizations had dramatically gone up by 350.0%. Attendance at community events is now robust, and sales at the local general store have gone up almost 20%.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Community-wide wellness measures have undergone dramatic public health changes since the development of a First Nations healing program involving opioid substitution therapy with buprenorphine-naloxone. Funding for such programs is ad hoc and temporary, and this threatens the survival of the described program and other such programs developing in this region, which has been strongly affected by an opioid-dependence epidemic.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25821874</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1715-5258</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Canadian family physician Medecin de famille canadien</Title><ISOAbbreviation>Can Fam Physician</ISOAbbreviation></Journal><ArticleTitle>Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.</ArticleTitle><Pagination><MedlinePgn>160-5</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To document the development of unique opioid-dependence treatment in remote communities that combines First Nations healing strategies and substitution therapy with buprenorphine-naloxone.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Quantitative measurements of community wellness and response to community-based opioid-dependence treatment.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Remote First Nations community in northwestern Ontario.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">A total of 140 self-referred opioid-dependent community members.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Community-developed program of First Nations healing, addiction treatment, and substitution therapy.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Community-wide measures of wellness: number of criminal charges, addiction-related medical evacuations, child protection agency cases, school attendance, and attendance at community events.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The age-adjusted adult rate of opioid-dependence treatment was 41%. One year after the development of the in-community healing and substitution therapy program for opioid dependence, police criminal charges had fallen by 61.1%, child protection cases had fallen by 58.3%, school attendance had increased by 33.3%, and seasonal influenza immunizations had dramatically gone up by 350.0%. Attendance at community events is now robust, and sales at the local general store have gone up almost 20%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Community-wide wellness measures have undergone dramatic public health changes since the development of a First Nations healing program involving opioid substitution therapy with buprenorphine-naloxone. Funding for such programs is ad hoc and temporary, and this threatens the survival of the described program and other such programs developing in this region, which has been strongly affected by an opioid-dependence epidemic.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kanate</LastName><ForeName>Dinah</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Folk</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Cirone</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Janet</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Kirlew</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Veale</LastName><ForeName>Terri</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Bocking</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Rea</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Len</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can Fam Physician</MedlineTA><NlmUniqueID>0120300</NlmUniqueID><ISSNLinking>0008-350X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>36B82AMQ7N</RegistryNumber><NameOfSubstance UI="D009270">Naloxone</NameOfSubstance></Chemical><Chemical><RegistryNumber>40D3SCR4GZ</RegistryNumber><NameOfSubstance UI="D002047">Buprenorphine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002047" MajorTopicYN="N">Buprenorphine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003153" MajorTopicYN="Y">Community Health Services</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009270" MajorTopicYN="N">Naloxone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058850" MajorTopicYN="N">Opiate Substitution Treatment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009293" MajorTopicYN="N">Opioid-Related Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25821874</ArticleId><ArticleId IdType="pmc">PMC4325865</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Subst Abuse Treat. 2010 Mar;38(2):153-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19801178</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Sep 4;349(10):949-58</Citation><ArticleIdList><ArticleId IdType="pubmed">12954743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Fam Med. 2007 Mar-Apr;5(2):146-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17389539</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2009 Feb;24(2):226-32</Citation><ArticleIdList><ArticleId IdType="pubmed">19089508</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2009 Dec 8;181(12):891-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19969578</ArticleId></ArticleIdList></Reference><Reference><Citation>Subst Abus. 2011 Oct;32(4):262-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22014257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Bocking, Natalie" sort="Bocking, Natalie" uniqKey="Bocking N" first="Natalie" last="Bocking">Natalie Bocking</name><name sortKey="Cirone, Sharon" sort="Cirone, Sharon" uniqKey="Cirone S" first="Sharon" last="Cirone">Sharon Cirone</name><name sortKey="Folk, David" sort="Folk, David" uniqKey="Folk D" first="David" last="Folk">David Folk</name><name sortKey="Gordon, Janet" sort="Gordon, Janet" uniqKey="Gordon J" first="Janet" last="Gordon">Janet Gordon</name><name sortKey="Kanate, Dinah" sort="Kanate, Dinah" uniqKey="Kanate D" first="Dinah" last="Kanate">Dinah Kanate</name><name sortKey="Kelly, Len" sort="Kelly, Len" uniqKey="Kelly L" first="Len" last="Kelly">Len Kelly</name><name sortKey="Kirlew, Mike" sort="Kirlew, Mike" uniqKey="Kirlew M" first="Mike" last="Kirlew">Mike Kirlew</name><name sortKey="Rea, Sara" sort="Rea, Sara" uniqKey="Rea S" first="Sara" last="Rea">Sara Rea</name><name sortKey="Veale, Terri" sort="Veale, Terri" uniqKey="Veale T" first="Terri" last="Veale">Terri Veale</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000226 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000226 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25821874
|texte= Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25821874" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |